Vivo Capital Fund IX, L.P.
CIK 0001750117
10% Owner
Filings
5
Latest Aug 10, 2023
Issuers covered
3
Showing
5 of 5
Page 1
Track record
5 of 6 open-market trades scored (83% price coverage) - 1 issuer without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 5 | 20% | -6.3% | -6.5% | +2.5% | -14.8% |
| 90 days | 5 | 0% | -28.8% | -28.9% | -9.3% | -45.8% |
| 180 days | 5 | 20% | -32.2% | -41.1% | +3.1% | -48.7% |
| 365 days | 5 | 0% | -16.7% | -16.8% | -3.7% | -27.4% |
Issuers
Companies where Vivo Capital Fund IX, L.P. has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| SRRA | Sierra Oncology, Inc. | 2 | Jan 31, 2022 |
| TARS | Tarsus Pharmaceuticals, Inc. | 2 | May 5, 2022 |
| IOBT | Io Biotech, Inc. | 1 | Aug 10, 2023 |
All filings
5 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|